e-detailer
Manufactured by Novo Nordisk, Tresiba is a once-daily, long-acting insulin degludec used to control high blood sugar in adults with diabetes. It is administered via subcutaneous injection. It has a duration of action that lasts up to 42 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir), making it a truly once-daily basal insulin.
We were approached to develop Tresiba's e-detailer inline with their existing printed detailer. This meant repurposing existing assets whilst also making sure elements were fit for purpose. Working alongside their external developers, we delivered an e-detailer that gave the Tresiba team the confidence to take to HCPs.
© The Partners